149 related articles for article (PubMed ID: 29442468)
41. [Pancreatic polypeptide (a review of the literature)].
Troitskaia VB
Fiziol Zh SSSR Im I M Sechenova; 1988 Aug; 74(8):1171-7. PubMed ID: 3058519
[TBL] [Abstract][Full Text] [Related]
42. [Serum levels of pancreatic polypeptide in normal subjects and in patients with pancreatic and renal disease].
Fan SL
Zhonghua Nei Ke Za Zhi; 1984 Oct; 23(10):615-8. PubMed ID: 6532673
[No Abstract] [Full Text] [Related]
43. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling.
Hocker JR; Postier RG; Li M; Lerner MR; Lightfoot SA; Peyton MD; Deb SJ; Baker CM; Williams TL; Hanas RJ; Stowell DE; Lander TJ; Brackett DJ; Hanas JS
Cancer Lett; 2015 Apr; 359(2):314-24. PubMed ID: 25637792
[TBL] [Abstract][Full Text] [Related]
44. [Secretory mechanism of pancreatic polypeptide].
Tsuda K; Seino Y; Sakurai H; Imura H; Mori K; Yamamura T
Nihon Rinsho; 1980; 38(1):16-23. PubMed ID: 6993722
[No Abstract] [Full Text] [Related]
45. [Pancreatic polypeptide (author's transl)].
Gepts W; de Mey J
Diabete Metab; 1978 Dec; 4(4):275-83. PubMed ID: 215473
[TBL] [Abstract][Full Text] [Related]
46. Secretion of pancreatic polypeptide in patients with pancreatic endocrine tumors.
Adrian TE; Uttenthal LO; Williams SJ; Bloom SR
N Engl J Med; 1986 Jul; 315(5):287-91. PubMed ID: 3014338
[TBL] [Abstract][Full Text] [Related]
47. Radioimmunoassay for pancreatic polypeptide, and its age-related changes in concentration.
O'Hare MM; Daly JG; Buchanan KD
Clin Chem; 1983 Nov; 29(11):1923-7. PubMed ID: 6313256
[TBL] [Abstract][Full Text] [Related]
48. Cerulein-induced pancreatic polypeptide secretion. Its inhibition by atropine and its possible role in regulating gallbladder relaxation.
Tsuda K; Seino Y; Sakurai H; Seino S; Takemura J; Kuzuya H; Adachi H; Imura H
Am J Gastroenterol; 1980 Oct; 74(4):355-8. PubMed ID: 7006382
[TBL] [Abstract][Full Text] [Related]
49. Alterations in hepatocyte insulin binding in chronic pancreatitis: effects of pancreatic polypeptide.
Seymour NE; Volpert AR; Lee EL; Andersen DK; Hernandez C
Am J Surg; 1995 Jan; 169(1):105-9; discussion 110. PubMed ID: 7817978
[TBL] [Abstract][Full Text] [Related]
50. Abnormal pancreatic polypeptide response to oral glucose loading diabetes mellitus.
Tsuda K; Sakurai H; Seino Y; Seino S; Tanigawa K; Kuzuya H; Mori K; Imura H
Clin Endocrinol (Oxf); 1980 Nov; 13(5):425-9. PubMed ID: 7226566
[TBL] [Abstract][Full Text] [Related]
51. Evidence for vagus-dependent pancreatic polypeptide-releasing factor in the antrum: studies with the autotransplanted dog pancreas.
Debas HT; Taylor IL; Seal AM; Passaro EP
Surgery; 1982 Aug; 92(2):309-14. PubMed ID: 7048599
[TBL] [Abstract][Full Text] [Related]
52. Hormonal studies in a patient with PP-producing tumors.
Bordi C; Sivelli R; Lampugnani R; Zanella E; Fajans SS
Horm Metab Res; 1985 Sep; 17(9):467-70. PubMed ID: 3899891
[TBL] [Abstract][Full Text] [Related]
53. Stimulation of pancreatic polypeptide secretion in the dog by hypoglycemic agent HB 699.
Ribes G; Trimble ER; Wollheim CB; Blayac JP; Loubatieres-Mariani MM
Am J Physiol; 1983 Apr; 244(4):E380-4. PubMed ID: 6340523
[TBL] [Abstract][Full Text] [Related]
54. [Pancreatic polypeptide (PP)].
Fujimoto S; Inagaki N; Seino Y
Nihon Rinsho; 2010 Jul; 68 Suppl 7():560-2. PubMed ID: 20960829
[No Abstract] [Full Text] [Related]
55. Pancreatic Polypeptide in Parkinson's Disease: A Potential Marker of Parasympathetic Denervation.
Knudsen K; Hartmann B; Fedorova TD; Østergaard K; Krogh K; Møller N; Holst JJ; Borghammer P
J Parkinsons Dis; 2017; 7(4):645-652. PubMed ID: 28922171
[TBL] [Abstract][Full Text] [Related]
56. [Pancreatic Diseases].
Schöfl R
Praxis (Bern 1994); 2016 Jun; 105(13):775-9. PubMed ID: 27329710
[TBL] [Abstract][Full Text] [Related]
57. A Reduced Pancreatic Polypeptide Response is Associated With New-onset Pancreatogenic Diabetes Versus Type 2 Diabetes.
Hart PA; Kudva YC; Yadav D; Andersen DK; Li Y; Toledo FGS; Wang F; Bellin MD; Bradley D; Brand RE; Cusi K; Fisher W; Mather K; Park WG; Saeed Z; Considine RV; Graham SC; Rinaudo JA; Serrano J; Goodarzi MO
J Clin Endocrinol Metab; 2023 Apr; 108(5):e120-e128. PubMed ID: 36404274
[TBL] [Abstract][Full Text] [Related]
58. A novel peptide nanomedicine for treatment of pancreatogenic diabetes.
Banerjee A; Onyuksel H
Nanomedicine; 2013 Aug; 9(6):722-8. PubMed ID: 23347897
[TBL] [Abstract][Full Text] [Related]
59. Pancreatic polypeptide regulates glucagon release through PPYR1 receptors expressed in mouse and human alpha-cells.
Aragón F; Karaca M; Novials A; Maldonado R; Maechler P; Rubí B
Biochim Biophys Acta; 2015 Feb; 1850(2):343-51. PubMed ID: 25445712
[TBL] [Abstract][Full Text] [Related]
60. Blunted pancreatic polypeptide responses in children with obesity of Prader-Willi syndrome.
Zipf WB; O'Dorisio TM; Cataland S; Sotos J
J Clin Endocrinol Metab; 1981 Jun; 52(6):1264-6. PubMed ID: 7014602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
